Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Is a |
Dibromopropamidine isethionate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Disinfectants and cleansers (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Anti-infective agent (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dibrompropamidine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amidine disinfectant |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dibromopropamidine isethionate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Is a |
Product containing dibrompropamidine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dibrompropamidine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Is a |
Product containing dibrompropamidine in ophthalmic dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Has manufactured dose form |
Ocular dose form (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Has manufactured dose form |
Eye ointment (product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dibrompropamidine isetionate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Has concentration strength numerator value |
1.5 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Has basis of strength substance (attribute) |
Dibrompropamidine isetionate |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Has precise active ingredient |
Dibrompropamidine isetionate |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Is a |
Product containing only dibrompropamidine in ocular dose form (medicinal product form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) |
Plays role |
Antiinfective therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|